TABLE OF CONTENTS  |  FRONT PAGE  |  NEXT ARTICLE |  PREVIOUS ARTICLE  |  UNC HOMEPAGE

Carolina is poised to take its place at the head of genomics

research


Jeffrey Houpt, the dean of the University's School of Medicine, recalled how three years ago Carolina did not have a dollar to spend on genomics.

The kitty's a little bigger now.

Houpt spoke at a Feb. 22 ceremony held to announce a $245 million public-private investment in a campuswide genome sciences initiative. Included in that investment are a $25 million anonymous gift and a $2.25 million federal appropriation, also announced that day.

Genomics involves the study of the sequence of DNA, which is the genetic material of living organisms. Knowledge of genes and their role in human disease may ultimately prove instrumental in cures for a wide variety of diseases. Internationally renowned scientists - including Francis Collins, director of the National Human Genome Research Institute and a medical school graduate - announced on Feb. 12 the first "map" of the human genome.

The $25 million gift to the School of Medicine will support the Michael Hooker Center for Proteomics. Proteomics is the area of specialization in genetics that catalogs the proteins expressed in cells. Proteins are instrumental in the processes that keep the body healthy or, when they go wrong, can lead to diseases such as cancer.

Hooker served as the University's chancellor from 1995 until he died of cancer in 1999.

The University received an anonymous gift of $1 million for genomics to honor Hooker the year he died. This gift was used to establish an endowed professorship in biology with a focus on genomics.

The new $2.25 million appropriation from the U.S. Department of Health and Human Services was secured last December with the support of the N.C. Congressional delegation, including Sen. Jesse Helms and Rep. David Price.

Chancellor James Moeser, in announcing the University's $245-million commitment, said Carolina has positioned itself to become a driving force in the genomics revolution. It will be a revolution, he said, that holds the promise of changing the way doctors treat diseases, researchers find and design breakthrough drugs and farmers grow crops.

"We aim to do our part in leading this breathtaking revolution spurred by DNA and the book of life," Moeser said.

The genesis of genomics at Carolina

Houpt and others at the University have been pushing to gain a toehold in the field of genomics for several years now.

In 1999, that toehold was secured when the University was awarded two important grants. The Howard Hughes Medical Institute gave the School of Medicine $2.6 million, to be distributed over four years, to help develop and staff a new genetics center. The University received a $5 million grant over five years from the National Institutes of Health to establish one of two "Regional Mutant Mouse Resource Centers" in the nation.

By 2000, the toehold Houpt had hoped for grew rapidly into a beachhead as the result of a series of sweeping developments.

The first was the arrival in July 2000 of Terry Magnuson, one of the world's most renowned scientists in mammalian genetics, along with the 15 members of his laboratory group and their 10,000 research mice.

Magnuson came from Case Western Reserve University in Cleveland to become the founding chair of the Department of Genetics in the University's School of Medicine. Some of the money used to recruit Magnuson and his team came from the more than $400,000 that the North Carolina Biotechnology Center gave the University for its genome sciences initiative.

The second major development came Oct. 12 when Moeser announced his intention to add new faculty positions in this area. The University has committed more than $50 million in recurring funds for 40 new faculty positions associated with genomics.

Moeser's announcement reinforced what Magnuson and others knew from the beginning: that to be cutting edge, genomics research at the University must cut across academic and medical disciplines and draw upon the expertise of many.

The new positions range across five health science schools - dentistry, medicine, nursing, pharmacy and public health - as well as the College of Arts and Sciences, the School of Information and Library Science and the School of Law.

Magnuson has said it was this atmosphere of collegiality and collaboration that was one of the things that attracted him to Carolina and would be one of the things he would use to attract others to Carolina as well.

Moeser said such collaboration would not be possible if not for the willingness of deans across campus to reallocate funds and faculty positions to the genome sciences initiative.

"The fact that deans are putting their own money behind this initiative shows how much they believe in what we're doing and how much they want to help this campus succeed," Moeser said.

Magnuson organized the Carolina Center for Genome Sciences as the place these professors and others from the various schools and disciplines can pursue their collaborative work.

"It's a special environment here," said Magnuson, who also is Sarah Graham Kenan professor. "Our goal is to achieve interaction and coordination across campus. In the opportunity we have to integrate the basic sciences with health affairs, we are uniquely positioned for the challenge of the post-genome era, a time after scientists have determined the sequence of DNA and are looking to provide meaning to it."

Since Magnuson's arrival in July, he has hired seven top assistant professors in the field. They are:

* David Threadgill from Vanderbilt University;

* Fernando de Manuel de Villena de L'Epine from Temple University and the Fels Institute for Cancer Research;

* Charles Perou from Stanford University;

* Deborah Threadgill from Vanderbilt;

* Frank Conlon from the National Institute for Medical Research in Mill Hill, United Kingdom;

* Larysa Halyna Pevny from the University of Sheffield, United Kingdom; and

* Shawn Ahmed, who will begin work in April, from the Medical Research Council in London.

At the same time, a number of faculty whose appointments are outside the Department of Genetics will be involved in research that will have key implications for genomics and genetics. Among them are:

* Jeffrey Dangl, John N. Couch professor in the Department of Biology;

* Patrick Flood, dean of the Dental Research Center;

* Alexander Tropsha, associate professor in the School of Pharmacy;

* Ed Davis, chair of the department of biostatistics;

* Gary Marchioni, Boshamer professor in the School of Information and Library Science;

* Steve Downs, associate professor of pediatrics; Susan Lord, professor of pathology and laboratory medicine and director of the Curriculum in Genetics and Molecular Biology;

* Larry Churchill, professor of social medicine;

* Richard Boucher Jr., Kenan professor of medicine;

* Shelton Earp, professor of medicine and pharmacology and director of the UNC Lineberger Comprehensive Cancer Center; and

* Dianne Holditch-Davis, professor in the School of Nursing.

Magnuson, in his remarks at the Feb. 22 ceremony, said the assembly of talent over the past year has moved the University to what he described as "the end of the beginning" in its genome sciences initiative.

The emerging challenge for the University now will be to maintain its focus and mobilize its forces in a coordinated way.

Magnuson also said a teaching component will be critical if the University is to fulfill the promise of becoming a leader in this emerging science. Toward that effort, the Department of Genetics has already established a human genetics minor and, in conjunction with the clinical departments, recently accepted its first medical genetics resident.

Room to grow

As genomics research grows in both scope and intensity, the building space it will need to flourish will grow in equal proportion.

A significant chunk of money that will be needed to meet that need has already been secured as a result of a third major development from 2000: state voters' approval in November of the $3.1 billion bond package for state universities and community colleges. The bond will pay for $499 million worth of construction at the University over the next decade.

Some of the University's share of the money will be used to help build four buildings affiliated with genomics research. Each of them will be paid for with various combinations of bond money, prior state appropriations, and money the University will raise from private gifts or state and federal grants.

Already under construction is the Medical Biomolecular Research Building, which will house the Department of Genetics and the Carolina Center for Genome Sciences. Bond money and prior state funding will account for $34 million of the $64 million needed to pay for the building.

The Science Complex, estimated to cost more than $400 million, will receive $88 million in bond money. The Bioinformatics Building, a $30 million project, will get $2 million in bond money. Finally, the Research and Teaching Building, a $39 million project, will receive $13 million in bond money.

At least some of the genomics enterprise could eventually be located on what is now the undeveloped Horace Williams tract off Airport Road.

Jack Evans, part of the four-member University team spearheading planning efforts for the property, said it is "both possible and likely but not definite" that Horace Williams could become the eventual home for genomics research.

Still, Evans said, it is clear that genomics has become a point of intellectual emphasis for the campus. It is equally clear that the Horace Williams property, with nearly 300 acres of its 1,000 acres to be developed, presents an opportunity for the University to grow. It would be logical, at this point, to use some of that land for this exciting new area of research, he said.

Where will it all lead?

The genomics revolution envisioned on this campus will have economic and medical implications that reach far beyond Chapel Hill.

The media attention that the genome sciences initiative received during the past two weeks only hints at the magnitude.

The News & Observer, in a Feb. 28 editorial, talked of how the Triangle will likely be a center for genomics research not only because of the University's commitment but also because of the $200 million that Duke University is putting in its own genome sciences project.

There will be competition between the two universities in this area, but Moeser has been quick to say that there should be and will be collaboration with Duke and N.C. State University as well. Such collaboration will only serve to strengthen the universities' competitive position with schools elsewhere, Moeser has said.

U.S. Rep. David Price, speaking at the Feb. 22 ceremony, recalled how it wasn't that long ago that the state of North Carolina was not known for being first in anything, in the South or anywhere else.

That's not true anymore, Price said.

Anywhere in the country he goes, everybody knows about the dynamic economy of the Triangle.

The foundation of that economy has been the intellectual capital of the three research universities, a foundation that past University leaders such as Frank Porter Graham and Bill Friday helped to build through their vision and leadership, Price said.

We cannot forget that we stand on their shoulders today, Price said, or that it's "our duty to build on that legacy."

"It's hard to think of anything more visionary than mapping the human genome."


TABLE OF CONTENTS  |  FRONT PAGE  |  NEXT ARTICLE |  PREVIOUS ARTICLE  |  UNC HOMEPAGE